Harry R Chobanian

This inventor holds 23 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 21 EPO patents, primarily in Antidiabetic Compounds. Top assignees: Merck Sharp + Dohme Corp., Merch Sharp & Dohne Corp. Rahway. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry R Chobanian. Retrieved from https://idiyas.com/inventor/harry-r-chobanian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 21 (Patent Applications = 11)

Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 34(Granted Patents)

Location History:

Kenilworth, NJ (US) (2018)
Aberdeen, NJ (US) (2012 - 2022)

Company Filing History:

22 out of 2,405

Merck Sharp + Dohme Corp.

patents

1 out of 1

Merch Sharp & Dohne Corp. Rahway

patent

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

NAV1.8 Inhibitors

Nicotinic Acetylcholine Receptors

Antidiabetic Compounds

Bicyclic Compounds

Heterocyclic Compounds

Thrombin Inhibitors

PAR-1 Receptor Antagonists

Potassium Channel Inhibitors

Oxazole Derivatives

Diazepine Sulfonamides

Himbacine Derivatives

Substituted Heteroaryl Compounds

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12344595 - 2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors (2025-07-01),

2. 12195445 - 2-amino-N-heteroaryl-nicotinamides as Na1.8 inhibitors (2025-01-14),

3. 11377438 - 2-amino-n-heteroaryl-nicotinamides as Na1.8 inhibitors (2022-07-05),

4. 11332463 - Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors (2022-05-17),

5. 11072602 - Antidiabetic heterocyclic compounds (2021-07-27),

6. 10968232 - Antidiabetic spirochroman compounds (2021-04-06),

7. 10676458 - Antidiabetic bicyclic compounds (2020-06-09),

8. 10662171 - Antidiabetic bicyclic compounds (2020-05-26),

9. 10131651 - [7,6]-fused bicyclic antidiabetic compounds (2018-11-20),

10. 10059667 - Antidiabetic compounds (2018-08-28),

11. 10000484 - Inhibitors of the renal outer medullary potassim channel (2018-06-19),

12. 9957219 - Antidiabetic bicyclic compounds (2018-05-01),

13. 9840512 - Antidiabetic bicyclic compounds (2017-12-12),

14. 9834563 - Antidiabetic substituted heteroaryl compounds (2017-12-05),

15. 9751881 - Inhibitors of the renal outer medullary potassium channel (2017-09-05),

Title: The Innovative Journey of Harry R Chobanian

Introduction: Harry R Chobanian, a talented inventor based in Aberdeen, NJ (US), has made significant contributions to the field of innovations with his creative mind and dedication to problem-solving.

Latest Patents: Harry R Chobanian holds several patents in various industries, showcasing his versatility and ingenuity in inventing new solutions to complex challenges.

Career Highlights: Throughout his career, Harry R Chobanian has demonstrated a keen ability to identify gaps in the market and develop groundbreaking inventions to fill those voids. His passion for innovation has led to the creation of revolutionary products that have positively impacted numerous industries.

Collaborations: Harry R Chobanian has collaborated with leading companies, research institutions, and universities to further enhance his inventions and bring them to the market. His collaborative spirit and willingness to work with others have been instrumental in the success of his projects.

Conclusion: In conclusion, Harry R Chobanian stands as a shining example of an inventor who has consistently pushed the boundaries of what is possible through his innovative thinking and relentless pursuit of excellence. His contributions to the world of inventions continue to inspire and pave the way for future innovators to follow in his footsteps.

Profile summary based on public USPTO records.